Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Extreme polymorphism in a vaccine antigen and risk of clinical malaria: implications for vaccine development.

Takala SL, Coulibaly D, Thera MA, Batchelor AH, Cummings MP, Escalante AA, Ouattara A, Traoré K, Niangaly A, Djimdé AA, Doumbo OK, Plowe CV.

Sci Transl Med. 2009 Oct 14;1(2):2ra5. doi: 10.1126/scitranslmed.3000257.

2.

Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trial.

Thera MA, Doumbo OK, Coulibaly D, Laurens MB, Kone AK, Guindo AB, Traore K, Sissoko M, Diallo DA, Diarra I, Kouriba B, Daou M, Dolo A, Baby M, Sissoko MS, Sagara I, Niangaly A, Traore I, Olotu A, Godeaux O, Leach A, Dubois MC, Ballou WR, Cohen J, Thompson D, Dube T, Soisson L, Diggs CL, Takala SL, Lyke KE, House B, Lanar DE, Dutta S, Heppner DG, Plowe CV.

PLoS One. 2010 Feb 4;5(2):e9041. doi: 10.1371/journal.pone.0009041.

3.

Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming 'vaccine resistant malaria'.

Takala SL, Plowe CV.

Parasite Immunol. 2009 Sep;31(9):560-73. doi: 10.1111/j.1365-3024.2009.01138.x. Review.

4.

Autosome-wide linkage analysis of hip structural phenotypes in the Old Order Amish.

Streeten EA, Beck TJ, O'Connell JR, Rampersand E, McBride DJ, Takala SL, Pollin TI, Uusi-Rasi K, Mitchell BD, Shuldiner AR.

Bone. 2008 Sep;43(3):607-12. doi: 10.1016/j.bone.2008.04.005. Epub 2008 Apr 25.

5.

Safety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: results of a phase 1 randomized controlled trial.

Thera MA, Doumbo OK, Coulibaly D, Diallo DA, Kone AK, Guindo AB, Traore K, Dicko A, Sagara I, Sissoko MS, Baby M, Sissoko M, Diarra I, Niangaly A, Dolo A, Daou M, Diawara SI, Heppner DG, Stewart VA, Angov E, Bergmann-Leitner ES, Lanar DE, Dutta S, Soisson L, Diggs CL, Leach A, Owusu A, Dubois MC, Cohen J, Nixon JN, Gregson A, Takala SL, Lyke KE, Plowe CV.

PLoS One. 2008 Jan 23;3(1):e1465. doi: 10.1371/journal.pone.0001465.

6.
7.

Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali.

Takala SL, Coulibaly D, Thera MA, Dicko A, Smith DL, Guindo AB, Kone AK, Traore K, Ouattara A, Djimde AA, Sehdev PS, Lyke KE, Diallo DA, Doumbo OK, Plowe CV.

PLoS Med. 2007 Mar;4(3):e93.

8.

Return of chloroquine antimalarial efficacy in Malawi.

Laufer MK, Thesing PC, Eddington ND, Masonga R, Dzinjalamala FK, Takala SL, Taylor TE, Plowe CV.

N Engl J Med. 2006 Nov 9;355(19):1959-66.

9.
10.

Genetic diversity in the Block 2 region of the merozoite surface protein 1 (MSP-1) of Plasmodium falciparum: additional complexity and selection and convergence in fragment size polymorphism.

Takala SL, Escalante AA, Branch OH, Kariuki S, Biswas S, Chaiyaroj SC, Lal AA.

Infect Genet Evol. 2006 Sep;6(5):417-24. Epub 2006 Mar 6.

11.

Wide distribution and diversity of members of the bacterial kingdom Acidobacterium in the environment.

Barns SM, Takala SL, Kuske CR.

Appl Environ Microbiol. 1999 Apr;65(4):1731-7.

Supplemental Content

Loading ...
Support Center